Loading...
Jardiance (Empagliflozin), an SGLT2 Inhibitor, Receives FDA Approval for the Treatment of Patients with Type 2 Diabetes
Saved in:
| Published in: | Am Health Drug Benefits |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Engage Healthcare Communications, LLC
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665046/ https://ncbi.nlm.nih.gov/pubmed/26629271 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|